Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
OpenAI just revealed what its new in-house team, OpenAI for Science, has been up to. The firm has released a free LLM-powered ...
Put rules at the capability boundary: Use policy engines, identity systems, and tool permissions to determine what the agent ...
Koi security researchers found that when NPM installs a dependency from a Git repository, configuration files such as a ...
A critical-severity vulnerability in the vm2 Node.js sandbox library, tracked as CVE-2026-22709, allows escaping the sandbox and executing arbitrary code on the underlying host system.
2dOpinion
Where AI browsers fall short
Unlike regular search engines, AI browsers suffer from algorithmic inconsistency due to their black-box nature — and even ...
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results